Biotech Analyst Karnauskas, along with a Key Opinion Leader and Arcus management, discuss gastric cancer on a conference call to be held on September 15 at 11:15 am hosted by Truist
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on RCUS:
- Arcus Biosciences participates in a conference call with Truist
- Cantor Fitzgerald biotech analyst to hold an analyst/industry conference call
- Arcus Biosciences price target raised to $23 from $21 at BofA
- Arcus Biosciences price target raised to $44 from $41 at Citi
- Arcus Biosciences rises 28.0%
Questions or Comments about the article? Write to editor@tipranks.com